Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

6.5K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
6.5K
Genetic Screens02:46

Genetic Screens

4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathological Classification and Clinical Characteristics of Growth Hormone-Secreting PitNETs.

Neuroendocrinology·2026
Same author

Prevalence, Digital Tools, and Management Strategies for Depression in Medical Students: A Narrative Review.

Advances in medical education and practice·2026
Same author

Letter to the editor: long-term endocrine trajectories and reoperation risk after surgery for Rathke's cleft cysts: a single-center cohort study of 177 patients.

Pituitary·2026
Same author

Single-Cell and Integrative Analyses Uncover Therapeutic Potential of RFX1-Mediated Cuproptosis in PitNETs.

Journal of integrative neuroscience·2026
Same author

Evaluating the image quality and brain microstructural exploration of mean apparent propagator-MRI-a pilot study.

BMC medical imaging·2026
Same author

Umbilical cord ulceration associated with placental abruption: a case report.

BMC pregnancy and childbirth·2026

Related Experiment Video

Updated: Jun 26, 2025

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
12:13

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

Published on: August 23, 2014

10.8K

Phenotype Transformation of PitNETs.

Zhenwei Li1, Yinzi Wu1, Guannan He1

  • 1Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Cancers
|May 11, 2024
PubMed
Summary
This summary is machine-generated.

Phenotype transformation in pituitary neuroendocrine tumors is a rare and unpredictable event. This review defines the phenomenon and discusses potential causes, including genetic factors and hormone bioactivity.

Keywords:
phenotype transformationpituitary adenomapituitary neuroendocrine tumorrecurrencesilent pituitary adenoma

More Related Videos

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
08:12

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

6.3K
Genomic Transformation of the Picoeukaryote Ostreococcus tauri
10:45

Genomic Transformation of the Picoeukaryote Ostreococcus tauri

Published on: July 13, 2012

15.7K

Related Experiment Videos

Last Updated: Jun 26, 2025

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
12:13

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

Published on: August 23, 2014

10.8K
High-throughput Screening for Protein-based Inheritance in S. cerevisiae
08:12

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

6.3K
Genomic Transformation of the Picoeukaryote Ostreococcus tauri
10:45

Genomic Transformation of the Picoeukaryote Ostreococcus tauri

Published on: July 13, 2012

15.7K

Area of Science:

  • Endocrinology
  • Oncology
  • Cell Biology

Background:

  • Pituitary neuroendocrine tumors (PitNETs) can undergo unpredictable phenotype transformation.
  • The causes and mechanisms underlying this rare phenomenon remain poorly understood.
  • Existing literature lacks a clear definition and systematic analysis of PitNET phenotype transformation.

Purpose of the Study:

  • To define phenotype transformation in pituitary neuroendocrine tumors.
  • To provide an overview of the clinical features and spectrum of this transformation.
  • To discuss potential underlying mechanisms of PitNET phenotype transformation.

Main Methods:

  • Systematic literature review of reported cases of pituitary neuroendocrine tumors exhibiting phenotype transformation.
  • Analysis of clinical features and outcomes associated with phenotype transformation.
  • Discussion of proposed molecular and cellular mechanisms based on existing research.

Main Results:

  • Phenotype transformation in PitNETs is a recognized but infrequent clinical occurrence.
  • The transformation presents a wide spectrum of clinical manifestations.
  • Potential contributing factors include alterations in prohormone convertase 1/3 (PC1/3), hormone bioactivity, gene mutations, and tumor cell plasticity.

Conclusions:

  • Phenotype transformation in pituitary neuroendocrine tumors is a complex phenomenon requiring clinical awareness.
  • Further research into the precise mechanisms is essential for better understanding and management.
  • Understanding these transformations may offer insights into tumor behavior and therapeutic strategies.